Delayed
TEL AVIV STOCK EXCHANGE
04:24:28 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
3,427
ILa
|
+1.57%
|
|
-6.03%
|
-9.98%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,219
|
10,159
|
9,418
|
9,608
|
8,501
|
-
|
-
|
Enterprise Value (EV)
1 |
6,219
|
10,159
|
9,418
|
9,608
|
8,501
|
8,501
|
8,501
|
P/E ratio
|
5.34
x
|
5.27
x
|
7.64
x
|
12.5
x
|
6.53
x
|
5.76
x
|
5.21
x
|
Yield
|
-
|
6.14%
|
3.57%
|
3.99%
|
8%
|
9.37%
|
11.1%
|
Capitalization / Revenue
|
371,544
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
371,544
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.05
x
|
0.93
x
|
0.91
x
|
0.75
x
|
0.72
x
|
0.7
x
|
Nbr of stocks (in thousands)
|
254,656
|
252,531
|
251,137
|
252,377
|
251,946
|
-
|
-
|
Reference price
2 |
24.42
|
40.23
|
37.50
|
38.07
|
33.74
|
33.74
|
33.74
|
Announcement Date
|
4/22/21
|
3/29/22
|
4/24/23
|
3/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
|
16,737
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
2,697
|
1,854
|
1,148
|
2,011
|
2,111
|
2,258
|
Net income
1 |
-
|
1,965
|
1,350
|
884.9
|
1,458
|
1,534
|
1,640
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
4.570
|
7.640
|
4.910
|
3.040
|
5.170
|
5.859
|
6.474
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
2.470
|
1.340
|
1.518
|
2.700
|
3.160
|
3.730
|
Announcement Date
|
4/22/21
|
3/29/22
|
4/24/23
|
3/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-57.05
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
1 |
-0.2300
|
0.2300
|
0.4400
|
2.590
|
1.100
|
1.460
|
1.460
|
1.470
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/31/23
|
8/24/23
|
11/29/23
|
3/27/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
26.3%
|
12.7%
|
7.5%
|
12.6%
|
12.7%
|
13%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
38.40
|
40.20
|
41.80
|
44.80
|
46.60
|
48.50
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/22/21
|
3/29/22
|
4/24/23
|
3/27/24
|
-
|
-
|
-
|
Last Close Price
33.74
ILS Average target price
49.5
ILS Spread / Average Target +46.71% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.98% | 2.26B | | +7.62% | 50.45B | | +5.93% | 49.81B | | +21.55% | 46.31B | | +13.62% | 42.31B | | +23.68% | 39.83B | | -1.75% | 28.46B | | -8.98% | 27.07B | | +27.21% | 26.32B | | -17.91% | 25.51B |
Other Life & Health Insurance
|